iOrganBio
Latest round
- Seed
Last raised
- Jul 2025
Total raised
- Undisclosed
Investors
- 1
About iOrganBio
iOrganBio, Inc.Founded in 2024, iOrganBio, Inc. operates from Chapel Hill, US, specializing in biotechnological innovations. The company has not undergone any significant pivots or structural changes since its inception.iOrganBio (iOB) specializes in advanced biotechnological solutions, primarily through its flagship CellForge™ Platform, which revolutionizes the creation and manufacturing of human cells and organoids. The platform integrates AI prediction, biological sensing, and automated 3D incubation to streamline complex cellular science into a programmable and scalable process. The core offerings focus on providing reliable, ready-to-use cells tailored to specific research and therapeutic needs, thereby addressing challenges in in vitro modeling and cell therapies. The company’s CellForge™ technology facilitates the development of a wide range of cell types, enhancing accessibility to advanced models and therapies.iOrganBio's revenue model is structured around partnerships and client contracts, primarily within the B2B sector, where the company provides tailored cell products and services to research institutions and biotech companies. Transactions typically involve agreements that outline the specifications of cell products derived from the CellForge™ Platform, ensuring alignment with client requirements. Pricing structures may vary based on the complexity and scale of cell production; however, specific figures for individual services are not disclosed.iOrganBio plans to advance its CellForge platform to support drug discovery, manufacturing, and cell therapies.00 mn will be utilized to accelerate the development of new features within the platform. The company aims to expand its market reach into additional regions, including Europe and Asia, by 2026, enhancing its ability to serve a broader range of clients in the biotechnology sector.
Who invested in iOrganBio
1 investor across 1 round
See all investors in iOrganBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 31, 2025
Amount
Undisclosed
Investors
Questions about iOrganBio
Who invested in iOrganBio?
iOrganBio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iOrganBio raised?
iOrganBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iOrganBio last raise money?
iOrganBio's most recent round on record is a Seed, in Jul 2025.
What does iOrganBio do?
iOrganBio is a biotechnology company.
Where is iOrganBio headquartered?
iOrganBio is headquartered in Chapel Hill, US.
Which VCs invest in companies like iOrganBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at iOrganBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like iOrganBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.